Prevalence and clinical implication of adverse childhood experiences and their association with substance use disorder among patients with schizophrenia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1687-8329
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prevalence and clinical implication of adverse childhood experiences and their association with substance use disorder among patients with schizophrenia ; volume:58 ; number:1 ; day:6 ; month:1 ; year:2022 ; pages:1-11 ; date:12.2022
The Egyptian journal of neurology, psychiatry and neurosurgery ; 58, Heft 1 (6.1.2022), 1-11, 12.2022
- Urheber
-
Yousef, Amira Mohamed
Mohamed, Amany Elshabrawy
Eldeeb, Seham Mahmoud
Mahdy, Rehab S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s41983-021-00441-x
- URN
-
urn:nbn:de:101:1-2022042404491899372360
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yousef, Amira Mohamed
- Mohamed, Amany Elshabrawy
- Eldeeb, Seham Mahmoud
- Mahdy, Rehab S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Circadian rhythmicity in schizophrenia male patients with and without substance use disorder comorbidity
Schizophrenia and substance use comorbidity: a genome-wide perspective
Stigma Towards People Living with Co-occurring Schizophrenia Spectrum and Substance Use Disorders: A Scoping Review
Adverse childhood experiences among patients with substance use disorders at a referral psychiatric hospital in Kenya
Pairwise genetic meta-analyses between schizophrenia and substance dependence phenotypes reveals novel association signals with pharmacological significance
A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection
Implication in finite posets with pseudocomplemented sections
Optimal insurance with adverse selection
Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation
CD73 polymorphisms are associated with schizophrenia
Premorbid development in twins with schizophrenia
Management of schizophrenia and comorbid substance use disorders: expert review and guidance
Circadian rhythmicity in schizophrenia male patients with and without substance use disorder comorbidity
Schizophrenia and substance use comorbidity: a genome-wide perspective
Stigma Towards People Living with Co-occurring Schizophrenia Spectrum and Substance Use Disorders: A Scoping Review
Adverse childhood experiences among patients with substance use disorders at a referral psychiatric hospital in Kenya
Pairwise genetic meta-analyses between schizophrenia and substance dependence phenotypes reveals novel association signals with pharmacological significance
A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection
Implication in finite posets with pseudocomplemented sections
Optimal insurance with adverse selection
Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation
CD73 polymorphisms are associated with schizophrenia
Premorbid development in twins with schizophrenia
Management of schizophrenia and comorbid substance use disorders: expert review and guidance
Circadian rhythmicity in schizophrenia male patients with and without substance use disorder comorbidity
Schizophrenia and substance use comorbidity: a genome-wide perspective
Stigma Towards People Living with Co-occurring Schizophrenia Spectrum and Substance Use Disorders: A Scoping Review
Adverse childhood experiences among patients with substance use disorders at a referral psychiatric hospital in Kenya
Pairwise genetic meta-analyses between schizophrenia and substance dependence phenotypes reveals novel association signals with pharmacological significance
A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection
Implication in finite posets with pseudocomplemented sections
Optimal insurance with adverse selection
Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation
CD73 polymorphisms are associated with schizophrenia
Premorbid development in twins with schizophrenia